Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Nature Metabolism
|
November 9, 2019
Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution
Joel T Haas, Luisa Vonghia, Denis A Mogilenko, et al.
Nature Metabolism
|
July 23, 2020
Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
Joel T Haas, Luisa Vonghia, Denis A Mogilenko, et al.
Virchows Archiv : an International Journal of Pathology
|
October 12, 2012
Serrated polyps of the colon: how reproducible is their classification?
Arzu Ensari, Banu Bilezikçi, Fatima Carneiro, et al.
Journal of Hepatology
|
December 3, 2014
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias
Xiaoye Schneider-Yin, Anne-Moon van Tuyll van Serooskerken, Marko Siegesmund, et al.
JCI Insight
|
July 7, 2017
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin
Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
Nature Communications
|
November 17, 2021
Organ-specific genome diversity of replication-competent SARS-CoV-2
Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, et al.
Cell Death and Differentiation
|
July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Cédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Journal of Crohn'S & Colitis
|
July 31, 2025
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Torsten Kucharzik, Stuart Taylor, Mariangela Allocca, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2014
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
Antonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Nature Metabolism
|
November 9, 2019
Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution
Joel T Haas, Luisa Vonghia, Denis A Mogilenko, et al.
Nature Metabolism
|
July 23, 2020
Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
Joel T Haas, Luisa Vonghia, Denis A Mogilenko, et al.
Virchows Archiv : an International Journal of Pathology
|
October 12, 2012
Serrated polyps of the colon: how reproducible is their classification?
Arzu Ensari, Banu Bilezikçi, Fatima Carneiro, et al.
Journal of Hepatology
|
December 3, 2014
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias
Xiaoye Schneider-Yin, Anne-Moon van Tuyll van Serooskerken, Marko Siegesmund, et al.
JCI Insight
|
July 7, 2017
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin
Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
Nature Communications
|
November 17, 2021
Organ-specific genome diversity of replication-competent SARS-CoV-2
Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, et al.
Cell Death and Differentiation
|
July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Cédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Journal of Crohn'S & Colitis
|
July 31, 2025
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Torsten Kucharzik, Stuart Taylor, Mariangela Allocca, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2014
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
Antonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, et al.
Page
of 7